FOUNDAYO FDA approval date

The FDA approved FOUNDAYO on 1 Apr 2026.

FDA approval date
1 Apr 2026

Drug identity has not yet been verified against registry records

Also recorded as ORFORGLIPRON CALCIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-04-01DayFOUNDAYOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220934", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["FOUNDAYO"], "active_ingredients": ["ORFORGLIPRON CALCIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260401", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026